This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.
DURHAM, N.C. — The COVID-19 pandemic has given a lot of biotech firms the motivation to try new things. That includes a Durham company working on a treatment for patients dealing with the virus. Brad Jones tells us more about their new device that could give doctors another tool in the battle, and this one is Made in North Carolina.
It still requires FDA emergency approval, which EmitBio is waiting for right now. If it’s approved, they say it could be available later this year. Find out more on the EmitBio website.
